Chromabond® Hr-xc – the New Mixed-mode Spe-phase for Basic Analytes

Chromatography

Chromabond® Hr-xc – the New Mixed-mode Spe-phase for Basic Analytes

11 Dec, 2008

Published over 17 years ago. See the latest and most current information on Chromatography.

Macherey-Nagel, a leading European SPE manufacturer, introduces a new
material for solid phase extraction. This innovative polymer-based strong cation exchanger with remarkable reversed-phase properties is ideal for enrichment of basic compounds.
The modern support polymer offers an optimised pore structure and high specific surface. Hereby good reproducibility as well as reliable and cost-efficient analysis are achieved.

The mixed-mode phase allows the possibility for more aggressive washing
procedures for matrix removal resulting in cleaner samples and protection of subsequently used HPLC or GC-machines and columns. So quantification of analytes, even from heavily contaminated samples, can be obtained, realising lower limits of detection also for critical matrices like urine or plasma (see application).

CHROMABOND® HR-XC from Macherey-Nagel is the perfect fit for basic analytes in combination with pure PR-phases like CHROMABOND® HR-X.
Detailed product information containing full application notes can be downloaded from the homepage www.mn-net.com or contact Macherey- Nagel directly under [email protected] for free samples. Please also feel free to ask for the new edited application guides for SPE or HPLC.

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Exhibitor registration opens for 2027 occupational safety and health trade fair in Düsseldorf
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
UK refining capacity falls to four plants after a second unplanned closure
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow